ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

12,276Medicare Part D Prescriptions Filled, Including Refills
$754K Total Retail Price of All Prescriptions
527 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 597 461 S3
LEVOTHYROXINE SODIUM 518 446
LISINOPRIL 435 364
SIMVASTATIN 424 346
OMEPRAZOLE 397 313
AMLODIPINE BESYLATE 393 350
FUROSEMIDE 356 316
METFORMIN HCL 314 253
LISINOPRIL-HYDROCHLOROTHIAZIDE 190 175
METOPROLOL TARTRATE 185 162
ZOLPIDEM TARTRATE 177 122
ATORVASTATIN CALCIUM 173 127
GLIMEPIRIDE 165 131
PRAVASTATIN SODIUM 165 150
GABAPENTIN 158 126
TRAMADOL HCL 156 116
CLOPIDOGREL 153 133
POTASSIUM CHLORIDE 146 137
ATENOLOL 146 127
WARFARIN SODIUM 139 127
RANITIDINE HCL 139 116
PLAVIX 135 115
SERTRALINE HCL 130 97
METOPROLOL SUCCINATE 117 99
HYDROCHLOROTHIAZIDE 116 110
CYMBALTA 115 65
PREDNISONE 115 98
NEXIUM 109 74
FENOFIBRATE 107 97
TRIAMTERENE-HYDROCHLOROTHIAZID 105 67
LOSARTAN-HYDROCHLOROTHIAZIDE 105 92
CITALOPRAM HBR 101 84
DONEPEZIL HCL 98 94
TRAZODONE HCL 98 62
CRESTOR 96 76
TAMSULOSIN HCL 94 90
AMOX TR-POTASSIUM CLAVULANATE 94 73
CARVEDILOL 90 84
NAPROXEN 82 74
FLUOXETINE HCL 76 40
PEN NEEDLE 73 60
LOSARTAN POTASSIUM 71 66
MELOXICAM 69 66
SPIRIVA 66 59
KLOR-CON M20 65 51
ALPRAZOLAM 62 39
PANTOPRAZOLE SODIUM 57 54
AZITHROMYCIN 57 48
FLUTICASONE PROPIONATE 57 50
ADVAIR DISKUS 57 48
LANTUS SOLOSTAR 55 50
ZALEPLON 52 46
SYNTHROID 52 40
PREMARIN 50 38 R
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.